Docetaxel in Treating Patients With Relapsed Prostate Cancer

Stopped Drug supplier stopped funding due to loss of study drug (docetaxel) patent.

Conditions

• Prostate Cancer

Interventions

• DRUG: docetaxel

Sponsor

OHSU Knight Cancer Institute

Collaborators

• [object Object]